166 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Buyback programs - May 2024 Monthly communication regarding buyback programs |
Liquidity contract | ||
2024 Annual General Assembly - results Results in French |
Shareholders´s Meeting | ||
Assemblée Générale Annuelle de Vetoquinol SA 28 mai 2024 Ordre du jour : |
Shareholders´s Meeting | ||
Buyback programs - April 2024 Monthly communication regarding buyback programs |
Liquidity contract | ||
Universal registration document 2023 XBRL version Universal Registration Document including the Annual Financial Report |
Reference document | ||
Universal registration document 2023 Universal Registration Document including the Annual Financial Report |
Reference document | ||
BALO : Notice of meeting Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions |
Shareholders´s Meeting | ||
2024 Calendar of financial communication Vetoquinol published its calendar of financial communication for 2024. |
Agenda | ||
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
Press releases communication | ||
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
Press releases communication |